- 1 -

C C LAND HOLDINGS LIMITED

中 渝 置 地 控 股 有 限 公 司g992
(Incorporated in Bermuda with limited liability)
Website: www.ccland.com.hk
(Stock Code: 1224)

APPOINTMENT OF EXECUTIVE DIRECTOR

The board of directors (the “Board”) of C C Land Holdings Limited (the “Company”) is
pleased to announce that Dr. Wong Kim Wing (“Dr. Wong”) will be appointed an additional
Executive Director of the Company with effect from 25 January 2008.

Dr. Wong, aged 46, is a registered architect and authorized person in Hong Kong. He is a
fellow member of The HK Institute of Architects and has over 20 years of experience in
property development and assets branding. Having graduated from The University of Hong
Kong with Architectural Degrees in 1984 and 1986, Dr. Wong also obtained his PhD Degree
in Finance at the Shanghai University of Finance and Economics in 2007. Prior to joining the
Company, Dr. Wong was a Director and Deputy General Manager (China Subsidiaries) and
Group Senior Project Manager of Sun Hung Kai Properties Group from 1994 to 2005. He was
also a Director of Project & Planning of The Link Management Limited from 2005 to January
2008. Save as disclosed above, Dr. Wong does not hold any position with the Company or its
subsidiaries, and has not held any directorship in other listed public companies in the last
three years.

There is a service contract between Dr. Wong and the Company which is subject to
termination by not less than 3 months’ notice in writing served by either party. Dr. Wong has
no fixed term of service with the Company but under the Company’s bye-laws, his
appointment as executive director will expire at the close of the first annual general meeting
after such appointment, and he will be eligible for re-election by shareholders at the meeting.
Thereafter, Dr. Wong will be subject to provisions in the bye-laws for retirement by rotation
and re-election. Dr. Wong will receive a basic salary of HK$253,000 plus a housing allowance
of HK$55,000 each month and be entitled to an year-end payment equivalent to one month of
his basic salary plus housing allowance (pro rata adjusted for any period shorter than a year),
which has been determined by the Board with reference to his duties and responsibilities and
the prevailing market conditions. The Remuneration Committee of the Board will review
annually the level of directors’ remuneration and make recommendation to the Board for
adjustment if necessary. Dr. Wong does not have any relationships with any directors, senior
management, substantial or controlling shareholders of the Company. As at the date of this
announcement, Dr. Wong is interested in 150,000 shares in the capital of the Company and a
share option under the Company’s existing share option scheme entitling him to subscribe for
2,000,000 shares at an exercise price of HK$15.22 per share. Save as disclosed above, Dr.
Wong does not have any interests in the shares of the Company within the meaning of Part
XV of the Securities and Futures Ordinance as at the date of this announcement.

- 2 -
Save as disclosed above, the Board is not aware of any other matters in relation to the above
appointment of director that need to be brought to the attention of shareholders of the
Company and there is no other information which is required to be disclosed pursuant to rule
13.51(2) of the Rules Governing the Listing of Securities on

The Board would like to take this opportunity to welcome Dr. Wong as a new member of the
Board.

By order of the Board
Lam How Mun Peter
Deputy Chairman and Managing Director
Hong Kong, 23 January 2008

As at the date of this announcement, the Board comprises Mr. Cheung Chung Kiu, Dr. Lam How Mun
Peter, Mr. Lam Hiu Lo, Mr. Leung Chun Cheong, Mr. Leung Wai Fai, Ms. Poon Ho Yee Agnes, Mr.
Tsang Wai Choi and Mr. Wu Hong Cho as Executive Directors; Mr. Wong Yat Fai as Non-executive
Director; and Mr. Lam Kin Fung Jeffrey, Mr. Leung Yu Ming Steven and Dr. Wong Lung Tak Patrick,
J.P. as Independent Non-executive Directors.